MARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2025 after the market close on Wednesday, October 29, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day. The conference call can be accessed using the following information: Webcast: ...

Transaction expected to close in fourth quarter with combined company to begin trading on the Nasdaq under the ticker “FUEL” Vertically Integrated business model combines state-of-the-art power generation with oil & gas production to power Bitcoin mining operations Post-Transaction combined entity expected to have an equity valuation range between US$220M-$343M SYDNEY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Innovation Beverage Group Ltd (“IBG” or the “Company”) (Nasdaq: IBG), an innovative developer, manufacture ...

OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall’25 Conference being held at the JW Marriott Austin, from Thursday, October 16 - Saturday, October 18 in Austin, TX. The CV Transforum is the leading conference for cardiovascular organizational performance solutions, uniting industry innovators and thought leaders from across th ...

SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasisScynexis will promptly wind-down and terminate the MARIO studyThe payment from GSK, combined with cash in hand and removal of future MARIO expenditures, extends the company’s cash runway to more than two yearsGSK remains committed to the commercialization of BREXAFEMME (ibrexafungerp tablets) JERSEY CITY, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: ...

Core Insights - The artificial intelligence boom is expected to significantly alter lifestyles and work environments, with recent AI deals indicating a rapid scale and pace of investment in necessary infrastructure [1] - OpenAI has secured approximately $1 trillion in deals this year, including a $300 billion agreement with Oracle for computer infrastructure over five years as part of a $500 billion data center project called Stargate [2] - OpenAI's partnerships include a $22 billion deal with CoreWeave for data center usage and an undisclosed amount partnership with Broadcom for chip development [2] - Nvidia has invested heavily in AI infrastructure, including a commitment of up to $6.3 billion to CoreWeave for cloud-computing capacity and a $40 billion purchase of Nvidia chips by Oracle for OpenAI's data center [3] - Concerns have been raised about inflated valuations of AI companies, with a Bain & Company report estimating a need for $2 trillion in annual revenue to support AI infrastructure by 2030, indicating an $800 billion shortfall [4] - Industry leaders argue that the current investments are essential for making AI a reality, emphasizing the fundamental nature of the infrastructure buildout [5]

VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce further strong drill results from the Jons Trend Zone at its Sela Creek Gold Project (“Sela Creek” or the “Project”) in Suriname. Results from holes 25DDH-SEL-034 through 36 confirm multiple stacked zones of gold mineralization and reinforce the interpretation of a large, continuous, and shallow dipping mineralized system at Jons Trend that ...

PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA FilingsExpanding ketamine indications, fortifying IP, enabling earlier partnerships, and accelerating FDA pathways - underpinned by PharmaTher's Digital Health AI division, leveraging the Company's FDA-approved ketamine ANDA CMC and KetaVault(TM) data advantage.October 15, 2025 8:00 AM EDT | Source: PharmaTher Holdings Ltd.Toronto, Ontario--(Newsf ...

The new channel will give advisors access to an investment platform headed by Stephanie Link, the firm’s chief investment strategist, portfolio manager and a long-time CNBC contributor. They will also get support from Randy Bullard, who Hightower recently hired from State Street to oversee a centralized investment management platform backed by institutional research and investment counsel from NEPC.While Restieri sees Hightower Signature as just one option within Hightower’s partnered network, he expects it ...

The investment giant readies a new business unit after President Trump issues an executive order regarding the inclusion of private assets in retirement plans. ...

WILMETTE, Ill., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that its abstract on the Phase 2 ALXN1840-WD-204 copper balance study has been selected for an oral presentation at the American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting® 2025, taking place in Washington, D.C., from November 7-11 ...